Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

[Preprint]. 2024 Jun 3:rs.3.rs-4244833. [Version 1] doi: 10.21203/rs.3.rs-4244833/v1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.

PMC Copyright notice

Extended data Fig. 3 — a-g Serum levels of seven out of 34 analytes obtained from 2141-V11 trial participants pre-treatment and 24 h after the first dose of 2141-V11 treatment. All panels show the fold induction from baseline (pre-treatment) of specific analytes, per patient; Left (green) shows data for six patients who received the two lower doses of 2141-V11 (0.7 and 2mg), and right (red) shows data for six patients who received the two higher doses of 2141-V11 (7 and 10mg). Analyte levels were determined using the ProcartaPlex^™ Human Cytokine & Chemokine Panel.